The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide

This publication has 14 references indexed in Scilit:

• Haploidentical T Cell–Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen–Matched Related or Unrelated Donor
  Transplantation and Cellular Therapy, 2016
• Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall
  Bone Marrow Transplantation, 2015
• Rabbit Anti–T Cell Globulin in Allogeneic Hematopoietic Cell Transplantation
  Transplantation and Cellular Therapy, 2015
• Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation
  Blood, 2015
• Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors
  Bone Marrow Transplantation, 2014
• Donor Cytomegalovirus Status Influences the Outcome of Allogeneic Stem Cell Transplant: A Study by the European Group for Blood and Marrow Transplantation
  Clinical Infectious Diseases, 2014
• Bone Marrow Compared with Peripheral Blood Stem Cells for Haploidentical Transplantation with a Nonmyeloablative Conditioning Regimen and Post-transplantation Cyclophosphamide
  Transplantation and Cellular Therapy, 2014
• Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patients
  Clinical Microbiology and Infection, 2014
• Donor Serostatus Has an Impact on Cytomegalovirus-Specific Immunity, Cytomegaloviral Disease Incidence, and Survival in Seropositive Hematopoietic Cell Transplant Recipients
  Transplantation and Cellular Therapy, 2011
• Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality
  Bone Marrow Transplantation, 2003